Comparing Real-time fMRI Neurofeedback Versus Sham for Altering Limbic and Eating Disturbances in Anorexia Nervosa
NCT ID: NCT04220112
Last Updated: 2022-12-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2020-03-01
2022-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Targeting Large-scale Networks in Depression With Real-time fMRI (Functional Magnetic Resonance Imaging) Neurofeedback
NCT05934604
Neurofeedback Removal of Emotional Information From Mind
NCT06460207
Cognitive Process-based Real-time fMRI Neurofeedback in MDD and Rumination
NCT04941066
Functional Magnetic Resonance Imaging (fMRI) Investigation Into Compulsivity in Anorexia
NCT03450239
Neurofeedback in Clinical High Risk
NCT06492343
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Aim 2: Identify the impact of rt-fMRI neurofeedback targeting limbic functioning on symptoms of AN. Hypothesis 1: Compared to the sham group, the amygdala neurofeedback group will exhibit improvements in self-reported emotion regulation and eating disorder symptoms over the study visits. Hypothesis 2: Compared to the sham group, the amygdala neurofeedback group will engage in less restrictive eating (i.e., will consume more calories) at a post-training test meal. Hypothesis 3: Across groups, decreased aversive amygdala reactivity and enhanced amygdala-PFC connectivity will predict reduced emotion dysregulation and eating disorder symptoms, and less restriction.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Real Time Functional MRI (rt-fMRI)
Real-time fMRI (rt-fMRI) neurofeedback (focused on amygdala down-regulation) intervention
Real-Time Functional Magnetic Resonance Imaging (RT-fMRI)
RT-fMRI neurofeedback targeting down-regulation of the amygdala
Sham
Sham-controlled group
Sham Procedure
RT-fMRI with feedback non-contingently tied to their activation patterns (activation patterns from a prior participant)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Real-Time Functional Magnetic Resonance Imaging (RT-fMRI)
RT-fMRI neurofeedback targeting down-regulation of the amygdala
Sham Procedure
RT-fMRI with feedback non-contingently tied to their activation patterns (activation patterns from a prior participant)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ability to read and speak in English
* Right-handed
Exclusion Criteria
* Acute suicidality, current substance use disorder, psychosis, or mania
* Contraindication for fMRI as determined by CMRR safety screening standards
* History of neurological disorder/injury (e.g., stroke; head injury with \> 10 minutes loss of consciousness)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Minnesota
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ann Haynos, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Minenesota
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Minnesota
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PSYCH-2019-28137
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.